Compositions and methods for activating cellular signaling pathways
AssigneeLifeVantage Corporation
InventorsBrian Dixon, Christina Beer, Qiana Martinez
Life of this patent
Estimating the term…
Abstract
Compositions and methods for increasing stress response and improving health and slowing the aging process in a user. A composition includes one or more of a first group consisting of milk thistle, ashwagandha, green tea, bacopa monnieri, and turmeric. The composition includes one or more of a second group consisting of acetyl-L-carnitine, quercetin, lipoic acid, coenzyme Q10, cysteine, and grape. The composition includes one or more of a third group consisting of wasabi, theacrine, copper, nicacin, cysteine, and olive extract.
Claims30
A composition comprising therapeutically effective amounts of:
- one or more of a first group consisting of milk thistle, ashwagandha, green tea, bacopa monnieri, and turmeric;
- one or more of a second group consisting of acetyl-L-carnitine, quercetin, lipoic acid, coenzyme Q10, cysteine, and grape;
- and
- one or more of a third group consisting of wasabi, theacrine, copper, nicacin, cysteine, and olive extract.
A method for slowing the effects of aging in a user by improving stress response, the method comprising:
- providing therapeutically effective amounts of a composition to the user, wherein the composition comprises:
- one or more of a first group consisting of milk thistle, ashwagandha, green tea, bacopa monnieri, and turmeric;
- one or more of a second group consisting of acetyl-L-carnitine, quercetin, lipoic acid, coenzyme Q10, cysteine, and grape;
- and
- one or more of a third group consisting of wasabi, theacrine, copper, nicacin, cysteine, and olive extract.
A composition comprising:
- an effective amount of a first group for increasing expression of each of an NQO1 gene in a body and a HMOX1 gene in the body, wherein the first group comprises milk thistle, ashwagandha, green tea, bacopa monnieri, and turmeric;
- an effective amount of a second group for increasing expression of an Nrf1 gene in the body and a PCG1-alpha gene in the body, wherein the second group comprises acetyl-L-carnitine, quercetin, lipoic acid, coenzyme Q10, cysteine, and grape leaf extract;
- and
- an effective amount of a third group for increasing expression of an NMNAT1 gene in the body and an NAMPT gene in the body, wherein the third group comprises wasabi, theacrine, copper niacin, cysteine, and olive leaf extract.
Dependencies are inferred from the claim text.